Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

POLYFLEX DIN 00849405

Status: Marketed
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: AMPICILLIN (AMPICILLIN TRIHYDRATE)

Health Canada record

Active ingredient(s)AMPICILLIN (AMPICILLIN TRIHYDRATE) 25 G
Dosage formPowder For Suspension
RouteIntramuscular
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date31-Dec-1990
Current status date08-Jun-2021
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing AMPICILLIN (AMPICILLIN TRIHYDRATE)

DINProductCompanyFormStrengthStatus
00020877TEVA-AMPICILLINTEVA CANADA LIMITEDCapsuleAMPICILLIN (AMPICILLIN TRIHYDRATE) 250 MGMarketed
00020885TEVA-AMPICILLINTEVA CANADA LIMITEDCapsuleAMPICILLIN (AMPICILLIN TRIHYDRATE) 500 MGMarketed
00857629POLYFLEXBOEHRINGER INGELHEIM (CANADA) LTD LTEEPowder For SuspensionAMPICILLIN (AMPICILLIN TRIHYDRATE) 10 GCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
260722021-06-15Supplement to a New Drug Submission (SNDS)Manufacturing Change
260212021-06-08New Drug Submission (NDS)CHANGE IN PRODUCT OWNERSHIP
255102021-03-23Supplement to a New Drug Submission (SNDS)ADDITION OF ANALTERNATE DRUG PRODUCT MANUFACTURING SITE, MANUFACTURING CHANGE
222422019-06-06Supplement to a New Drug Submission (SNDS)MANUFACTURING CHANGE
191582017-04-13Supplement to a New Drug Submission (SNDS)ADDITION OF MANUFACTURING SITE
117662010-09-29New Drug Submission (NDS)Change in ownership
36292004-05-19New Drug Submission (NDS)
61072002-05-02Supplement to a New Drug Submission (SNDS)ALTERNATE SOURCE OF ACTIVE INGREDIENT
68871998-06-01New Drug Submission (NDS)
Request a quote for POLYFLEX

How to read a Canadian DIN record